These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 31031978)

  • 21. Comparing neoadjuvant chemotherapy with or without radiation therapy for pancreatic ductal adenocarcinoma: National Cancer Database cohort analysis.
    Oba A; Wu YHA; Colborn KL; Karam SD; Meguid C; Al-Musawi MH; Bao QR; Gleisner AL; Ahrendt S; Schulick RD; Del Chiaro M
    Br J Surg; 2022 Apr; 109(5):450-454. PubMed ID: 35136963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preoperative Concurrent Chemoradiotherapy Versus Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer: Phase II Randomized Study.
    Wang X; Zhao DB; Yang L; Chi Y; Zhao H; Jiang LM; Jiang J; Tang Y; Li N; Liu WY; Dou LZ; Zou SM; Xue LY; Ren JS; Tian YT; Che X; Guo CG; Bai XF; Sun YM; Wang SL; Song YW; Liu YP; Fang H; Li YX; Jin J
    Front Oncol; 2022; 12():870741. PubMed ID: 35574368
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Phase I Study Examining the Feasibility and Safety of an Aerobic Exercise Intervention in Patients With Rectal Cancer During and After Neoadjuvant Chemoradiotherapy.
    Morielli AR; Usmani N; Boulé NG; Tankel K; Severin D; Nijjar T; Joseph K; Courneya KS
    Oncol Nurs Forum; 2016 May; 43(3):352-62. PubMed ID: 27105196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between pathologic features of peripheral nerves and postoperative anal function after neoadjuvant therapy for low rectal cancer.
    Koushi K; Nishizawa Y; Kojima M; Fujii S; Saito N; Hayashi R; Ochiai A; Ito M
    Int J Colorectal Dis; 2016 Dec; 31(12):1845-1852. PubMed ID: 27655392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Short-term Outcomes in Patients with Carcinoma of the Esophagus and Gastroesophageal Junction Receiving Neoadjuvant Chemotherapy or Chemoradiation before Surgery. A Prospective Study.
    Nusrath S; Thammineedi SR; Vijaya Narsimha Raju KV; Patnaik SC; Pawar S; Santa A; Rajappa SJ; Mallavarapu KM; Raju K; Murthy S
    Rambam Maimonides Med J; 2019 Jan; 10(1):. PubMed ID: 29993360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does the computed tomography perfusion imaging improve the diagnostic accuracy in the response evaluation of esophageal carcinoma to the neoadjuvant chemoradiotherapy? Preliminary study.
    Djuric-Stefanovic A; Saranovic D; Micev M; Stankovic V; Plesinac-Karapandzic V; Pesko P; Stojakov D; Sabljak P; Bjelovic M
    J BUON; 2014; 19(1):237-44. PubMed ID: 24659670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Feasibility and limitations of combined treatment for lateral pelvic lymph node metastases in rectal cancer.
    Zheng YZ; Yan FF; Luo LX
    World J Clin Oncol; 2024 May; 15(5):591-593. PubMed ID: 38835841
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Feasibility and preliminary effectiveness of a physical exercise training program during neoadjuvant chemoradiotherapy in individual patients with rectal cancer prior to major elective surgery.
    Heldens AF; Bongers BC; de Vos-Geelen J; van Meeteren NL; Lenssen AF
    Eur J Surg Oncol; 2016 Sep; 42(9):1322-30. PubMed ID: 27156145
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Negative impact of pretreatment anemia on local control after neoadjuvant chemoradiotherapy and surgery for rectal cancer.
    Lee H; Park HC; Park W; Choi DH; Kim YI; Park YS; Park JO; Chun HK; Lee WY; Kim HC; Yun SH; Cho YB; Park YA
    Radiat Oncol J; 2012 Sep; 30(3):117-23. PubMed ID: 23170290
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A study of inflammation-based predictors of tumor response to neoadjuvant chemoradiotherapy for locally advanced rectal cancer.
    Krauthamer M; Rouvinov K; Ariad S; Man S; Walfish S; Pinsk I; Sztarker I; Charkovsky T; Lavrenkov K
    Oncology; 2013; 85(1):27-32. PubMed ID: 23816828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Utility of preoperative chemoradiotherapy for advanced esophageal carcinoma.
    Kuroda J; Yoshida M; Kitajima M; Yanagisawa A; Matsubara T; Yamaguchi T; Osamura Y; Ohta K; Kubota K; Beck Y; Yamashita Y
    J Gastroenterol Hepatol; 2012 Apr; 27 Suppl 3():88-94. PubMed ID: 22486878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictive factors for early distant metastasis after neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
    Park H
    World J Gastrointest Oncol; 2021 Apr; 13(4):252-264. PubMed ID: 33889277
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparison of short-term efficacy and perioperative safety between neoadjuvant therapy and total neoadjuvant therapy in patients with locally advanced rectal cancer].
    Zhai ZW; Zhang KN; Wang C; Han JG; Ma HC; Wei GH; Yang Y; Wang ZJ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):274-280. PubMed ID: 32192307
    [No Abstract]   [Full Text] [Related]  

  • 34. Exercise motivation in rectal cancer patients during and after neoadjuvant chemoradiotherapy.
    Morielli AR; Usmani N; Boulé NG; Severin D; Tankel K; Nijjar T; Joseph K; Courneya KS
    Support Care Cancer; 2016 Jul; 24(7):2919-26. PubMed ID: 26847350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
    Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
    [No Abstract]   [Full Text] [Related]  

  • 36. Current status of and perspectives regarding neoadjuvant chemoradiotherapy for locally advanced esophageal squamous cell carcinoma.
    Saeki H; Nakashima Y; Zaitsu Y; Tsuda Y; Kasagi Y; Ando K; Imamura Y; Ohgaki K; Ito S; Kimura Y; Egashira A; Oki E; Morita M; Maehara Y
    Surg Today; 2016 Mar; 46(3):261-7. PubMed ID: 25740123
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The potential benefit of adjuvant chemotherapy in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy is not predicted by tumor regression grade.
    Bohlok A; Hendlisz A; Bouazza F; Galdon MG; Van de Stadt J; Moretti L; El Nakadi I; Liberale G
    Int J Colorectal Dis; 2018 Oct; 33(10):1383-1391. PubMed ID: 29984385
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in treatment patterns for patients with locally advanced rectal cancer in the United States over the past decade: An analysis from the National Cancer Data Base.
    Sineshaw HM; Jemal A; Thomas CR; Mitin T
    Cancer; 2016 Jul; 122(13):1996-2003. PubMed ID: 27074300
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Feasibility, Safety, and Preliminary Efficacy of Exercise During and After Neoadjuvant Rectal Cancer Treatment: A Phase II Randomized Controlled Trial.
    Morielli AR; Usmani N; Boulé NG; Severin D; Tankel K; Joseph K; Nijjar T; Fairchild A; Courneya KS
    Clin Colorectal Cancer; 2021 Sep; 20(3):216-226. PubMed ID: 34158253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Additional chemotherapy and salvage surgery for poor response to chemoradiotherapy in rectal cancers.
    Engineer R; Ostwal V; Arya S; Gupta P; Chopra S; Patil P; Jatal S; Saklani A
    Asia Pac J Clin Oncol; 2017 Aug; 13(4):322-328. PubMed ID: 28304150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.